Mr. F. Mohazia: Stem Cell Treatment for ALS

Patient: Mr. F. Mohazia

Gender: Male

Country:  Jordan

Conditions/reasons for treatment:

ALS,diagnosed with Amyotrophic lateral sclerosis 2 years ago. Has shown a rapid increase in related symptoms of the disease. Loss f mobility and stregnth in all limbs and a bility to speak. General organ health is good.

Initial Assessment was performed on Mr. Mohazir – He shows sign of upper motor neuron lesion involving all limbs Rt > Lt , deep tendon reflex generally grade 4+ , slight muscular atrophy both lower limbs, marked muscular atrophy on upper limbs especially Rt. Side. Muscular function – on lower limb extensor Gr 1-2 Flexor grade 2-3 , upper limb flexor grade 1-2 , extensor grade 1, slurred speech, difficult to swallow.


Patient’s expectations of possible improvement after therapy:

To stop the progression of the disease and hopefully restore some of the mobility and ability to communicate.

Start Date of therapy program: 20/2/10

Treatment location: Bangkok, Thailand

Treatment program: 10 days

    *  100,000,000 blood group matched umbilical cord blood mononuclear stem cells
    * 20,000,000 human umbilical cord blood-derived stem cells

               (10,000,000  cd34+ stem cells and 10,000,000 mesenchymal stem cells)

 

    * 1x IV injection of mononuclear stem cells
    * 2x IV injections of cd34+ umbilical cord blood stem cells
    * 2x Lumbar pucture injections of mesenchymal umbilical cord blood stem cells
    * 6x stem cell growth factor injections
    * 4x HOT: Hemotogenous Oxidation therapy
    * 10x QRS

 
 
Day 1: 20 feb 2010

Treatment:     

   1. Hemotogenous Oxidation therapy was performed successfully
   2. Intravenous administration of 100 million Blood Group A+ purified cord blood derived mononuclear cell
   3. nerve growth factor number 96 UF intramuscular

 

No immediate side effect observed
 
Day 2: 21 Feb 2010

 

The patients complaint about abdominal pain. After evaluating – he has been diagnosed Food Poisoning – symptomatic treatment provided

 

Treatment

 

Buscopan oral

Ultracarbon Oral

Veragel DMS oral

 

QRS Bioresonance

Hematogenous Oxidation Therapy

 
Day 3: 22 Feb 2010

 

Condition stable, no abdominal pain, mild headache

 

Treatment

 

Acetaminophen 2 tab

QRS

Hematogenous Oxidation Therapy

Nerve Growth Factor 96 UF intramuscular

 

 
Day 4: 23 Feb 2010

Patient condition: Stable

 

Treatment

QRS

Intravenous administration of purified cord blood derived hematopoietic stem cell 5 million cells

Nerve Growth Factor 96 PC – intramuscular

 
Day 5: 24 Feb 2010

 

Patient condition: Stable

 

Treatment

QRS

Intrathecal administration of 5 millions cell purified cord blood derived mesenchymal stem cell via lumbar puncture.

Nerve growth factor 92 PC

 
Day 6: 25 Feb 2010

 

Treatment

QRS

H.O.T.
 
Day 7: 26 Feb 2010

 

Treatment

QRS

IV 5 million cells – CD34+ purified cord blood derived

 
Day 8: 27 Feb 2010

 

Treatment

 

Intrathecal administration 5 million hUCB MSC via lumbar puncture

69 PC growth factor
 
Day off: 28 feb 2010

 
Day 9: 1 March 2010

 

QRS

15 PC Growth Factor
 
Day 10: 2 March 2010

 

Final assessment: stable condition

Quantum assessment consultation

 

Advice:

   1. chiropractic adjustment to release neck blockage
   2. high fiber diet to maintain normal bowel movement
   3. Active rehabilitation program at home
   4. Exercise chest muscle
         1. Take Deep breath
         2. Hold
         3. Slowly exhale
         4. Coughing
   5. after each exercise session – swallow the saliva to maintain reflex



...............................................................................................................................
 
Comments and updates on patient over past 2 months:
After 2 weeks:

Will update